Trials / Recruiting
RecruitingNCT04899466
Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence
A Prospective Study Evaluating the Efficacy of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- RedDress Ltd. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, single arm study, consisting of 20 women with abdominal surgical wound dehiscence that requires secondary closure. The participants will receive a weekly application of ActiGraft for 4 weeks, or until complete healing of the wound (the earlier of the two). An historic matched-control group of 20 patients will be compared retrospectively
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ActiGraft | Whole blood clot (WBC) gel |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2021-05-24
- Last updated
- 2024-11-15
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04899466. Inclusion in this directory is not an endorsement.